Let’s Build The Future of Cancer Immunotherapy Together
Cypre partners with biopharma teams advancing immunotherapy, bispecifics, and next-generation targeted agents.
Contact us to explore MOA collaborations, biomarker discovery, or strategic platform
deployment.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Developing in the NAMs era?
Partner with Cypre to generate translational insights using our 3D tumor microenvironment organoid platform. From targeting the tumor or stroma, to modulating the immune system, we’re built for collaboration.
© Cypre Inc. All rights reserved.